Etiological Investigation of Diabetes in Young Adults Presenting with Apparent Type 2 Diabetes
Overview
Affiliations
Objective: Young adults with newly diagnosed apparent type 2 diabetes present the clinician with a wide differential diagnosis of possible etiology, including autoimmune and genetic causes as well as young-onset type 2 diabetes (YT2D). The characteristics of these groups have been described, but it is not known in which subjects investigation for etiology may be beneficial.
Research Design And Methods: A total of 268 unselected U.K. Caucasian subjects diagnosed at ages 18-45 years and not treated with permanent insulin for < or =6 months were studied. All subjects underwent clinical assessment and screening for GAD antibodies (GADA) and tyrosine phosphatase IA-2 antibodies (IA-2A). Screening for a common mutation in the hepatocyte nuclear factor-1 alpha (HNF-1 alpha) gene and the common mitochondrial mutation was performed in the antibody-negative subjects. Subjects without insulin resistance were selected for sequencing of the HNF-1 alpha gene.
Results: A specific etiology was defined in 11.6% of the 268 subjects and in 24.7% of the lean subjects. Twenty-six subjects (9.7%) were positive for a beta-cell antibody, one subject had familial partial lipodystrophy and the lamin A/C mutation R482W, and two subjects had the mitochondrial mutation A3243G. Two of 15 selected subjects had HNF-1 alpha mutations, the novel missense mutation A501T, and the previously reported R583Q.
Conclusions: This unselected series shows that there is considerable heterogeneity in apparent YT2D. beta-Cell autoantibodies should be performed in all those presenting at ages 18-45 years. Genetic investigations can be targeted to phenotypically defined subjects. The finding of a specific etiology will allow individualization of management and give patients valuable information about their condition.
Update on Monogenic Diabetes in Korea.
Yang Y, Kwak S, Park K Diabetes Metab J. 2020; 44(5):627-639.
PMID: 33115208 PMC: 7643597. DOI: 10.4093/dmj.2020.0214.
Sahoo S, Zaidi G, Vipin V, Chapla A, Thomas N, Yu L Indian J Med Res. 2019; 149(4):479-488.
PMID: 31411171 PMC: 6676834. DOI: 10.4103/ijmr.IJMR_1004_17.
Siraj E, Homko C, Wilson L, May P, Rao A, Calles J Front Endocrinol (Lausanne). 2018; 9:32.
PMID: 29487566 PMC: 5816742. DOI: 10.3389/fendo.2018.00032.
Najmi L, Aukrust I, Flannick J, Molnes J, Burtt N, Molven A Diabetes. 2016; 66(2):335-346.
PMID: 27899486 PMC: 5860263. DOI: 10.2337/db16-0460.
Wakil S, Muiya N, Tahir A, Al-Najai M, Baz B, Andres E Dis Markers. 2014; 2014:291419.
PMID: 25057215 PMC: 4098619. DOI: 10.1155/2014/291419.